Related Experiment Video
Updated: Jun 10, 2025

06:39
Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure
Published on: August 28, 2009
14.0K
A Novel Bioluminescent Biosensor Quantifying Intramolecular Interaction and Levels of Pyroptosis Effector GSDMD
Tynan Kelly1, Simran Bhandari1, Madeleine Carew1
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
Cells
|October 15, 2024
Summary
Researchers developed a novel Gasdermin D biosensor to track pyroptosis, a cell death process linked to inflammation. This tool aids in studying inflammatory diseases and finding new drug therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Gasdermin D (GSDMD) executes pyroptosis, a crucial inflammatory programmed cell death pathway.
- GSDMD's role in diseases like heart failure and cancer highlights its therapeutic potential.
- Studying GSDMD function is difficult due to its lack of enzymatic activity.
Purpose of the Study:
- To develop a novel bioluminescent biosensor for Gasdermin D (GSDMD).
- To enable real-time monitoring of GSDMD dynamics and pyroptosis in living cells.
- To facilitate drug discovery for GSDMD-targeted therapies in inflammatory diseases.
Main Methods:
- Utilized NanoBiT technology to create a GSDMD bioluminescent biosensor (GSDMD-BS).
- Quantified intramolecular interactions, uncleaved GSDMD levels post-caspase-1 cleavage, and expression in live cells.
- Validated sensor accuracy in vitro and demonstrated in vivo potential using a xenograft mouse model.
Main Results:
- Successfully developed a functional GSDMD bioluminescent biosensor (GSDMD-BS).
- The biosensor accurately measures GSDMD levels and cleavage events in vitro.
- Demonstrated the biosensor's applicability in a preclinical mouse model.
Conclusions:
- The novel GSDMD biosensor provides a valuable tool for real-time pyroptosis monitoring.
- This technology will accelerate research into GSDMD and pyroptosis.
- The biosensor can be applied to high-throughput drug screening for inflammatory diseases.

